Among 47 patients with any of several forms of idiopathic inflammatory myositis (IIM) who took efgartigimod (Vyvgart Hytrulo) ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

In part, that is because biologic drugs are accounting for a larger share of new launches than in the past and are starting to outpace small-molecule ... and Argenx's Vyvgart Hytrulo (efgartigimod ...

UCB also notes that unlike monoclonal antibody C5 inhibitors Zilbrysq is a smaller peptide molecule ... for Vyvgart Hytrulo (efgartigimod alfa), a subcutaneous FcRn blocker, in June. That drug ...

Q4 2024 Earnings Call Transcript May 29, 2025 Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.22 ...

where Vyvgart, for example, is a well-loved drug in MG, but where we feel like we have potential to differentiate on efficacy and clinical benefit. And I was pleased to see, for example ...

It would help the trials—and patients—if more people were tested for Alzheimer’s earlier on, so that they could be enrolled ...

Scientists at Northwestern University have developed the largest open-access resource of its kind to help researchers shave ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Once the platform generates a road map for synthesizing a drug molecule, the method is validated in the laboratory with high-throughput experimentation, often done by robots. “The robots make us ...

Avidity has been given the go-ahead by the FDA to request accelerated approval of delpacibart braxlosiran—potentially the ...